BioNTech shifts focus from COVID-19 vaccines to mRNA-based cancer therapies amid financial challenges. Q4 2024 earnings per share reached €1.08, down from €1.90 the previous year, with annual revenues decreasing…
Poland's Health Minister leads a key meeting in Brussels on January 30 regarding pharmaceutical legislation. The meeting focuses on addressing drug safety and hospital cybersecurity as Poland takes its leadership…
### Gastroenteritis Strikes Educational Facility in Iwate Prefecture On January 14, authorities in Iwate Prefecture announced a troubling outbreak of gastroenteritis at a local educational and childcare facility. Close to…